Cardiac resynchronization pacing without defibrillator capability: Is this a viable option?

Europace

Volumn 8, Issue 7, 2006, Pages 499-501

  Ermis, Cengiz ^a   Benditt, David G ^b  

^a AKDENIZ UNIVERSITY   (Turkey)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cardiac resynchronization; Heart failure; Implantable defibrillators; Quality of life

Indexed keywords

ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CONSUMER; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATION; DISEASE EXACERBATION; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL TIME; SYSTOLE;

CARDIAC PACING, ARTIFICIAL; CLINICAL TRIALS; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE, CONGESTIVE; HUMANS; QUALITY OF LIFE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33745622403     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eul047     Document Type: Article

References (20)

1. Park RC, Little WC, O'Rourke RA. Effect of alteration of the left ventricular activation sequence on the left ventricular end-systolic pressure-volume relation in closed-chest dogs. Circ Res 1985;57:706-17.
2. Blanc JJ, Etienne Y, Gilard M et al. Evaluation of different ventricular pacing sites in patients with severe heart failure. Results of an acute hemodynamic study. Circulation 1997;96:3273-7.
3. Leclercq C, Cazeau S, Le Breton H et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol 1998;32:1825-31.
4. Etienne Y, Mansourati J, Gilard M et al. Evaluation of left ventricular based pacing in patients with congestive heart failure and atrial fibrillation. Am J Cardiol 1999;83:1138-40.
5. Cazeau S, Leclercq C, Lavergne T et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80.
6. Nelson GS, Berger RD, Fetics BJ et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left-bundle branch block. Circulation 2000;102:3053-9.
7. Mansourati J, Etienne Y, Gilard M et al. Left ventricular-based pacing in patients with chronic heart failure: Comparison of acute hemodynamic benefits according to underlying heart disease. Eur J Heart Fail 2000;2:195-9.
8. Auricchio A, Stellbrink C, Sack S et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-33.
9. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al.; MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
10. Higgins SL, Hummel JD, Niazi IK et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003;42:1454-9.
11. Young JB, Abraham WT, Smith AL et al.; Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003;289:2685-94.
12. Bristow MR, Saxon LA, Boehmer J et al. for the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
13. Cazeau S, Ritter P, Lazarus A et al. Multisite pacing for end-stage heart failure: Early experience. Pacing Clin Electrophysiol 1996;19:1748-57.
14. Blanc JJ, Benditt DG, Gilard M, Eteinne Y, Mansourati J, Lurie KG. A method for permanent transvenous left ventricular pacing. Pacing Clin Electrophysiol 1998;21:2021-4.
15. Kass DA, Chen CH, Curry C et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999;99:1567-73.
16. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al.; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;14;352:1539-49.
17. Saxon LA, De Marco T, Schafer J, Chatterjee K, Kumar UN, Foster E; VIGOR Congestive Heart Failure Investigators. Effects of long-term biventricular stimulation resynchronization on echocardiographic measures of remodeling. Circulation 2002;105:1304-10.
18. Adamson PB, Kleckner KJ, VanHout WL, Srinivasan S, Abraham WT. Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation 2003;108:266-9.
19. Evonich RF, Maheshwari A, Gardiner JC, Khasnis A, Kantipudi S, Ip JH et al. Implantable cardioverter defibrillator therapy in patients with ischemic or non-ischemic cardiomyopathy and non-sustained ventricular tachycardia. J Interv Cardiac Electrophysiol 2004;11:59-65.
20. Ermis C, Seutter R, Zhu AX et al. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter defibrillators. J Am Coll Cardiol 2005; 46:2258-63.